原料药出口在中国医保产品出口中所占的比重超过50%,金融危机状况下的中国原料药出口走势倍受关注。2009年1-6月,中国原料药出口呈现出数量逐渐回升,价格基本稳定;重点市场数量萎缩,新兴市场增幅明显;大宗商品成交低迷,部分品种市场回暖;经营公司略有增加,经营规模普遍下降等特点。出口发展既面临结构性缺陷引发低水平同质化竞争现象、政策性因素降低传统竞争优势、金融危机引起贸易环境恶化、质量质疑造成“中国制造”信誉受损、企业规模小,经营秩序乱等困难和问题,也具有国际市场仍在扩大、药品市场刚性需求、部分产品定价话语权较大、品质提高和结构优化,市场竞争能力增强、承接国际医药外包注入新的活力、扩大出口政策起到推动作用等有利条件。综合各方面因素,作者认为,2009年中国原料药出口量将与2008年持平或有所增长,出口价格将保持稳定,出口额将可能有所增长,2009年中国原料药出口发展依然充满希望。 The exports of APIs have accounted for more than 50% of the total exports of Medicare products in China. The export trend of APIs under the financial crisis has drawn much attention. From January to June 2009, the export volume of APIs in China showed a gradual recovery and the prices were basically stable. The number of key markets contracted and the growth rate of emerging markets was significant. Commodity turnover was sluggish and some of the market rebound. Operating companies increased slightly and the scale of operation was generally Decline and so on. Export development faces structural flaws that lead to the phenomenon of low level of homogenization, policy factors reduce the traditional competitive advantage, the financial crisis has led to the deterioration of the trade environment, and the quality of the products has led to the deteriorating reputation of “Made in China”, the small scale of enterprises and the business order Chaos and other difficulties and problems, but also with the international market is still expanding, the rigid demand for drugs in the market, some products pricing power larger, higher quality and structural optimization, enhanced market competitiveness, to undertake the international pharmaceutical outsourcing to inject new vitality and expand export policies Play a facilitating role and other favorable conditions. Based on various factors, the author believes that in 2009 China’s API exports will be flat or increase with 2008, export prices will remain stable, the export value may be increased in 2009 China’s export of pharmaceutical raw materials is still full of hope for the development.